default author photo

The Nigerian Breast Cancer Study Group

Independent

SCHOLARLY PAPERS

1

DOWNLOADS

102

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Pragmatic Clinical Trial Assessing Response to Neoadjuvant Taxotere and Trastuzumab in Nigerian Women with Her2-Positive Breast Cancer (ARETTA): First Report from the Nigerian Breast Cancer Study Group

Number of pages: 20 Posted: 18 Dec 2024
University of Ibadan, Lagos State University, Obafemi Awolowo University, Obafemi Awolowo University, Lagos State University, University of Illinois at Chicago - College of Medicine, University of Chicago, University of Chicago, University of Chicago, University of Chicago, University of Ibadan, University of Ibadan, Obafemi Awolowo University, University of Lagos, University of Lagos, University of Lagos, Obafemi Awolowo University, Lagos State University, University of Ibadan, Lagos State University, University of Lagos, University of Lagos, Obafemi Awolowo University, Lagos State University, University of Ibadan, University College Hospital Ibadan, University of Ibadan, University of Chicago, Marshfield Clinic Health System, University of Ibadan, Lagos University Teaching Hospital, Lagos University Teaching Hospital, Cornell University - Weill Cornell Medicine, University of Chicago, University of Chicago, Lagos State University, University of Ibadan, University of Chicago and Independent
Downloads 102 (679,608)

Abstract:

Loading...

breast cancer, Her 2 positive, Docetaxel, Herceptin, response, Nigerian, biomarker